Trillium Diagnostics, Vivione deal

Diagnostic company Vivione will acquire Trillium for $1.5 million in cash and $4 million in stock.

Read the full 162 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE